| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000024630 |
| Receipt No. | R000028335 |
| Official scientific title of the study | Study of oral health control and probiotics in the elderly people |
| Date of disclosure of the study information | 2016/11/03 |
| Last modified on | 2019/02/26 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Study of oral health control and probiotics in the elderly people | |
| Title of the study (Brief title) | Oral health and probiotics | |
| Region |
|
|
| Condition | |||
| Condition | healthy elderly people | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | YES | ||
| Objectives | |
| Narrative objectives1 | The aim is to assess the effect of lactic acid bacteria-containing tablets on oral health control. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Change of oral health condition by the oral administration of lactic acid bacteria-containing tablets for 2 months: Plaque index, tongue coating, probing pocket depth, bleeding on probing, volatile sulfur compound. |
| Key secondary outcomes | composition of oral microbiota |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | The subjects ingest the tablets containing Lactobacillus salivarius WB21 for 2 months. The dose throughout the test period is maintained at 1 tablet 3 times per day (2.0 x 10^9 colony forming units per day), taken orally after eating and mouth cleaning. | |
| Interventions/Control_2 | The subjects ingest the placebo tablets for 2 months. The dose throughout the test period is maintained at 1 tablet 3 times per day, taken orally after eating and mouth cleaning. The placebo tablets are same composition except for L. salivarius WB21. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Healthy elderly people | |||
| Key exclusion criteria | not wearing complete denture prostheses, not currently visiting a dentist for treatment, not using antibiotics within 3 months, having no smoking habit, having no adverse reactions to lactose or fermented milk products, having no serious metabolic disorders, having no cancer | |||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Takao Hirofuji |
| Organization | Fukuoka Dental College |
| Division name | Department of General Dentistry |
| Address | 2-15-1, Tamura Sawara-ku, Fukuoka, Japan |
| TEL | 81-91-801-0411 |
| hirofuji@college.fdcnet.ac.jp | |
| Public contact | |
| Name of contact person | Nao Taniguchi |
| Organization | Fukuoka Dental College |
| Division name | Department of Preventive and Public Health Dentistry |
| Address | 2-15-1, Tamura Sawara-ku, Fukuoka, Japan |
| TEL | 81-91-801-0411 |
| Homepage URL | |
| naojsz@college.fdcnet.ac.jp | |
| Sponsor | |
| Institute | Fukuoka Dental College |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ministry of Education, Culture, Sports, Science and Technology |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 筑紫南コミュニティセンター(福岡県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000028335 |